Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04714346
Other study ID # 2019-08/384
Secondary ID
Status Completed
Phase
First received
Last updated
Start date August 8, 2019
Est. completion date May 8, 2020

Study information

Verified date January 2021
Source Saglik Bilimleri Universitesi
Contact n/a
Is FDA regulated No
Health authority
Study type Observational [Patient Registry]

Clinical Trial Summary

Laparoscopic surgery is an alternative to open surgical techniques for reasons such as less blood loss,less need for transfusion, shorter discharge time. In laparoscopic cases, various positions are given to patients, especially trendelenburg, in order to remove organs and see the area of the operation more easily. The Trendelenburg position causes cerebrovascular changes.Several studies have reported an increase in intracranial pressure (ICP)at the Trendelenburg position. There are also studies that show brain tissue oxygen saturation (SctO2) decreases in this position. Research has reported that cerebral perfusion pressure decreases if the position lasts longer.When pneumoperitonium is administered during laparoscopic surgery, cerebral blood flow may increase as a result of the increase in PaCO2.Brain tissue oxygen saturation depends on blood flow.There is also an inverse ratio between end tidal CO2. To prevent deterioration of cerebral function, methods are needed that determine the onset of desaturation and make early intervention possible. The method,known as near-infrared spectroscopy (NIRS), offers a fixed non-invasive and safe method of determining cerebral desaturation.In addition, NIRS has the potential to improve patient outcomes, reduce postoperative complications and duration of post-anesthesia care.Changes in NIRS measurement values associated with position, especially today, are seen in cerebral perfusion in patients undergoing major surgery, oxygenation and postop have been associated with cognitive dysfunction in the process.Postoperative cognitive dysfunction is associated with increased mortality and therefore it is very important to identify factors that increase risk in order to take appropriate protective measures.Intracerebral ischemia and desaturation may be responsible for the development of POCD. In this study, we aimed to observe NIRS changes due to Trendelenburg position and pneumoperitonium in patients undergoing laparoscopic major abdominal oncological surgery and to examine the effect of POCD on early stage.


Description:

In Saglık Bilimleri University, Ankara A.Y. Oncology Research and Trainnee Hospital, Anesthesiology and reanimation clinic,patients who are scheduled for elective laparoscopic major abdominal surgery after the approval of the Ethics Committee will be enrolled in the study. From the beginning of the study, successive patients were included in the study. Measurement values were taken and recorded using the NIRS device in our clinic throughout the case in patients 18 years of age and older. All patients were evaluated with MMSE in preoperative and postoperative period. According to power analysis using mean and standard deviation to determine the sample size of the patients to be taken in this process, at least 52 patients were planned to be included in the study. After preoperative MMSE testing, ASA scores, comorbidities,demographic data, drugs used in anesthesia, vasopressor use, pneumoperitonium pressures and duration, angle and duration of trendelenburg position, and vital parameters were recorded with NIRS device in our clinic. MMSE test was re-administered to all patients in the first week of postoperative period. Patients with preoperative MMSE score (M0) 24/30 points and above; postoperative 7th day (M1) was re-evaluated and those with a fall of 4 points and more in M1 score than M0 score were assessed as POCD. NIRS measurements were taken perioperative and their correlation with POCD was looked at. Inclusion criteria; - 18 years and older, - preoperative 24 points and above on MMSE test(M0) - Laparoscopic major abdominal oncological surgery planned patients who will receive general anesthesia. Exclusion criteria; - People with a history of cerebral ischemia or hemorrhage, - Those with a history of neurodegenerative disease, - Those with diagnosed carotid stenosis, - Those with a score of 23 and below on the MMSE test, - Those with a history of Carotid Endarterectomy, - Patients who have undergone aneurysm surgery, - Those who are addicted to alcohol, - Those with psychiatric illness, - Those who have undergone cervical surgery, - Those with a history of transient ischemic attacks,


Recruitment information / eligibility

Status Completed
Enrollment 53
Est. completion date May 8, 2020
Est. primary completion date May 8, 2020
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - 18 years and above, - 24 points and above on MMSE test, - Laparoscopic major abdominal oncological surgery planned patients who will receive general anesthesia Exclusion Criteria: - People with a history of cerebral ischemia or hemorrhage, - Those with a history of neurodegenerative disease, - Those with diagnosed carotid stenosis, - Those with a score of 23 and below on the MMSE test, - Those with a history of Carotid Endarterectomy, - Patients who have undergone aneurysm surgery, - Those who are addicted to alcohol, - Those with psychiatric illness, - Those who have undergone cervical surgery, - Those with a history of transient ischemic attacks,

Study Design


Related Conditions & MeSH terms


Intervention

Other:
no interventions
there is no intervention

Locations

Country Name City State
Turkey SBU. Ankara A.Y. Oncology Research and Training Hospital Ankara

Sponsors (1)

Lead Sponsor Collaborator
Saglik Bilimleri Universitesi

Country where clinical trial is conducted

Turkey, 

Outcome

Type Measure Description Time frame Safety issue
Primary MMSE changings in POCD Lowest MMSE score is 0;highest is 30. 24 is the limit of mild cognitive decline. In MMSE, to evaluate cognitive changings 4 point of decline is meaningful. Primarily, In our study, First patients with preoperative MMSE score(M0) 24/30 points and above will be re-evaluated on postoperative seventh day(M1) and those with a decrease of 4 points and greater than M0 score in M1 score will be evaluated as POCD. each patient in seven days
Secondary NIRS measurement correlation NIRS value of rSO2 changings was looked at. Rate of %20 and above were recorded as meaningful.
Secondarily, NIRS measurements will be taken perioperative and their correlation with POCD will be looked at.
each patient in seven days
See also
  Status Clinical Trial Phase
Completed NCT02141932 - Pocket-size Cardiovascular Ultrasound in Stroke N/A
Recruiting NCT02662751 - Performing a Low-dose, Whole-body Angiography as the First Element of an Imaging Assessment Following Stroke / TIA N/A
Completed NCT02038725 - MIDNOR-TIA - a Study of 600 Patients With Transient Ischemic Attack
Completed NCT01528462 - Sleep Disorders Managed and Assessed Rapidly in Transient Ischemic Attack (TIA) and In Early Stroke
Withdrawn NCT00069069 - E-Selectin Nasal Instillation to Prevent Secondary Stroke Phase 1
Recruiting NCT02701998 - The Stroke and Exercise Program N/A
Completed NCT02450760 - Connected Health Blood Pressure Monitoring In Stroke and TIA Patients N/A
Completed NCT02089074 - Systematic Follow up of Drug Treatment by Pharmacists in Secondary Prevention After Transient Ischemic Attack N/A
Completed NCT00250380 - The Study on Profile and Genetic Factors of Aspirin Resistance (ProGEAR Study) Phase 4
Terminated NCT00991029 - Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) Trial Phase 3
Recruiting NCT06407154 - Chronical Illness-related Limitations of the Ability to Cope With Rising Temperatures: an Observational Study, 2nd Wave
Active, not recruiting NCT01509924 - Cognitive and Physical Functions in Patients With Transient Ischemic Attack. A Randomized Controlled Trial of Physical Activity on Prescription up to One Year After the Event N/A
Completed NCT00061022 - Safety and Effectiveness of NXY-059 for the Treatment of Patients Who Have Suffered From a Stroke Phase 3
Completed NCT02415855 - Canadian Pradaxa Acute Stroke Safety Study
Completed NCT02799511 - Biomarkers for the Diagnosis of Transient Ischemic Attack N/A
Completed NCT00514800 - Home Blood Pressure Monitoring Trial Phase 3
Recruiting NCT00553241 - Short-Term Prognosis Evaluation of Transient Ischemic Attack Patients Using ABCD2 Score N/A
Active, not recruiting NCT00201461 - Evaluation of the STARFlex® Septal Closure System in Patients With a Stroke or TIA Due to the Possible Passage of a Clot of Unknown Origin Through a Patent Foramen Ovale (PFO) Phase 2/Phase 3
Completed NCT00119626 - Safety and Effectiveness of NXY-059 for the Treatment of Patients Who Have Suffered From a Stroke Phase 3
Terminated NCT05961163 - Chronical Illness-related Limitations of the Ability to Cope With Rising Temperatures: an Observational Study